Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Monlunabant by Inversago Pharma for Obesity: Likelihood of Approval
Monlunabant is under clinical development by Inversago Pharma and currently in Phase II for Obesity. According to GlobalData, Phase II...
Monlunabant by Inversago Pharma for Metabolic Syndrome: Likelihood of Approval
Monlunabant is under clinical development by Inversago Pharma and currently in Phase II for Metabolic Syndrome. According to GlobalData, Phase...
Monlunabant by Inversago Pharma for Hypertriglyceridemia: Likelihood of Approval
Monlunabant is under clinical development by Inversago Pharma and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II...
Monlunabant by Inversago Pharma for Diabetic Nephropathy: Likelihood of Approval
Monlunabant is under clinical development by Inversago Pharma and currently in Phase II for Diabetic Nephropathy. According to GlobalData, Phase...
NN-9441 by Inversago Pharma for Obesity: Likelihood of Approval
NN-9441 is under clinical development by Inversago Pharma and currently in Phase I for Obesity. According to GlobalData, Phase I...